Sulfonamide derivatives as multi-target agents for complex diseases

被引：190

作者：

Apaydin, Sinem ^{[1
]}

Torok, Marianna ^{[1
]}

机构：

[1] Univ Massachusetts, Dept Chem, 100 Morrissey Blvd, Boston, MA 02125 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2019年 / 29卷 / 16期

关键词：

Sulfonamide; Multi-target approach; Complex diseases; Sulfa-drugs; Polypharmacology; CARBONIC-ANHYDRASE I; TARGET-DIRECTED LIGANDS; BIOLOGICAL EVALUATION; CRYSTAL-STRUCTURE; INHIBITORY-ACTIVITY; POTENTIAL TREATMENT; DUAL INHIBITORS; ISOZYME-II; DESIGN; VITRO;

D O I：

10.1016/j.bmcl.2019.06.041

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

Sulfonamide derivatives are frequently seen structural motifs in medicinal chemistry. Almost a century after Gerhard Domagk's pioneering work leading to the first sulfonamide antibiotic Prontosil, sulfa-drugs are still widely utilized in various pharmaceutical applications due to their antibacterial, antiviral, antimalarial, antifungal, anticancer, antidepressant, or other properties. In the past few years, the interest in sulfonamides has increased as their broad range of bioactivity and versatile structure make them excellent candidates for repurposing old drugs or developing new multi-target agents in the emerging field of polypharmacology. This digest aims to provide an overview of recent advances in sulfonamide-based bioactive compounds, their importance in drug discovery and development emphasizing multi-target approaches for complex diseases, and their novel contribution to contemporary medicinal chemistry.

引用

页码：2042 / 2050

页数：9

共 74 条

[21] Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moieties [J].

Garaj, V ;

Puccetti, L ;

Fasolis, G ;

Winum, JY ;

Montero, JL ;

Scozzafava, A ;

Vullo, D ;

Innocenti, A ;

Supuran, CT .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (21) :5427-5433

[22] Carbonic anhydrase inhibitors: Novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX [J].

Garaj, V ;

Puccetti, L ;

Fasolis, G ;

Winum, JY ;

Montero, JL ;

Scozzafava, A ;

Vullo, D ;

Innocenti, A ;

Supuran, CT .

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (12) :3102-3108

[23] Synthesis of 4-(thiazol-2-ylamino)-benzenesulfonamides with carbonic anhydrase I, II and IX inhibitory activity and cytotoxic effects against breast cancer cell lines [J].

Gawad, Nagwa M. Abdel ;

Amin, Noha H. ;

Elsaadi, Mohammed T. ;

Mohamed, Fatma M. M. ;

Angeli, Andrea ;

De Luca, Viviana ;

Capasso, Clemente ;

Supuran, Claudiu T. .

BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (13) :3043-3051

[24] Toward a treatment of diabesity: Rational design, synthesis and biological evaluation of benzene-sulfonamide derivatives as a new class of PTP-1B inhibitors [J].

Ghareb, Nagat ;

El-Sayed, Norhan M. ;

Abdelhameed, Reda ;

Yamada, Koji ;

Elgawish, Mohamed Saleh .

BIOORGANIC CHEMISTRY, 2019, 86 :322-338

[25] In-Vitro Anticancer Evaluation of Some Novel Thioureido-Benzensulfonamide Derivatives [J].

Ghorab, Mostafa M. ;

Alsaid, Mansour S. ;

Al-Dosari, Mohammed S. ;

El-Gazzar, Marwa G. ;

Arbab, Ahmed H. .

MOLECULES, 2016, 21 (04)

[26] Synthesis and biological evaluation of solubilized sulfonamide analogues of the phosphatidylinositol 3-kinase inhibitor ZSTK474 [J].

Giddens, Anna C. ;

Gamage, Swarna A. ;

Kendall, Jackie D. ;

Lee, Woo-Jeong ;

Baguley, Bruce C. ;

Buchanan, Christina M. ;

Jamieson, Stephen M. F. ;

Dickson, James M. J. ;

Shepherd, Peter R. ;

Denny, William A. ;

Rewcastle, Gordon W. .

BIOORGANIC & MEDICINAL CHEMISTRY, 2019, 27 (08) :1529-1545

[27] Discovery of novel dual inhibitors against Mdm2 and Mdmx proteins by in silico approaches and binding assay [J].

Golestanian, Sahand ;

Sharifi, Amirhossein ;

Popowicz, Grzegorz M. ;

Azizian, Homa ;

Foroumadi, Alireza ;

Szwagierczak, Aleksandra ;

Holak, Tad A. ;

Amanlou, Massoud .

LIFE SCIENCES, 2016, 145 :240-246

[28] Advances in rationally designed dual inhibitors of HIV-1 reverse transcriptase and integrase [J].

Gu, Shuang-Xi ;

Xue, Ping ;

Ju, Xiu-Lian ;

Zhu, Yuan-Yuan .

BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (21) :5007-5016

[29] New anticancer drug candidates sulfonamides as selective hCA IX or hCA XII inhibitors [J].

Gul, Halise Inci ;

Yamali, Cem ;

Sakagami, Hiroshi ;

Angeli, Andrea ;

Leitans, Janis ;

Kazaks, Andris ;

Tars, Kaspars ;

Ozgun, Dilan Ozmen ;

Supuran, Claudiu T. .

BIOORGANIC CHEMISTRY, 2018, 77 :411-419

[30]

Guo X, 2015, MOL BIOL CELL, V26

← 1 2 3 4 5 6 7 8 →